126 related articles for article (PubMed ID: 32546700)
1. KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1.
Ma JB; Bai JY; Zhang HB; Jia J; Shi Q; Yang C; Wang X; He D; Guo P
Cell Death Dis; 2020 Jun; 11(6):466. PubMed ID: 32546700
[TBL] [Abstract][Full Text] [Related]
2. KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy.
Jia J; Zhang HB; Shi Q; Yang C; Ma JB; Jin B; Wang X; He D; Guo P
Theranostics; 2019; 9(19):5464-5477. PubMed ID: 31534497
[TBL] [Abstract][Full Text] [Related]
3. HDAC-mediated deacetylation of KLF5 associates with its proteasomal degradation.
Tao R; Zhang B; Li Y; King JL; Tian R; Xia S; Schiavon CR; Dong JT
Biochem Biophys Res Commun; 2018 Jun; 500(3):777-782. PubMed ID: 29679567
[TBL] [Abstract][Full Text] [Related]
4. Krüppel-like factor 5 promotes apoptosis triggered by tumor necrosis factor α in LNCaP prostate cancer cells via up-regulation of mitogen-activated protein kinase kinase 7.
Shi Q; Gao Y; Xu S; Du C; Li F; Tang XS; Jia J; Wang X; Chang L; He D; Guo P
Urol Oncol; 2016 Feb; 34(2):58.e11-8. PubMed ID: 26480897
[TBL] [Abstract][Full Text] [Related]
5. The deacetylase HDAC1 negatively regulates the cardiovascular transcription factor Krüppel-like factor 5 through direct interaction.
Matsumura T; Suzuki T; Aizawa K; Munemasa Y; Muto S; Horikoshi M; Nagai R
J Biol Chem; 2005 Apr; 280(13):12123-9. PubMed ID: 15668237
[TBL] [Abstract][Full Text] [Related]
6. Nitazoxanide inhibits acetylated KLF5-induced bone metastasis by modulating KLF5 function in prostate cancer.
Huang Q; Liu M; Zhang D; Lin BB; Fu X; Zhang Z; Zhang B; Dong JT
BMC Med; 2023 Feb; 21(1):68. PubMed ID: 36810084
[TBL] [Abstract][Full Text] [Related]
7. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
He P; Yang JW; Yang VW; Bialkowska AB
Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
[TBL] [Abstract][Full Text] [Related]
8. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
9. Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription.
Gao Y; Wu K; Chen Y; Zhou J; Du C; Shi Q; Xu S; Jia J; Tang X; Li F; Hui K; He D; Guo P
Oncotarget; 2015 Dec; 6(41):43791-805. PubMed ID: 26544730
[TBL] [Abstract][Full Text] [Related]
10. KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation.
Ci X; Xing C; Zhang B; Zhang Z; Ni JJ; Zhou W; Dong JT
Mol Cancer; 2015 Apr; 14():91. PubMed ID: 25896712
[TBL] [Abstract][Full Text] [Related]
11. Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERβ and KLF5.
Nakajima Y; Akaogi K; Suzuki T; Osakabe A; Yamaguchi C; Sunahara N; Ishida J; Kako K; Ogawa S; Fujimura T; Homma Y; Fukamizu A; Murayama A; Kimura K; Inoue S; Yanagisawa J
Sci Signal; 2011 Apr; 4(168):ra22. PubMed ID: 21487105
[TBL] [Abstract][Full Text] [Related]
12. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.
Liu S; Li X; Lin Z; Su L; Yan S; Zhao B; Miao J
Cancer Lett; 2018 Mar; 416():11-23. PubMed ID: 29247827
[TBL] [Abstract][Full Text] [Related]
13. DNMT1-maintained hypermethylation of Krüppel-like factor 5 involves in the progression of clear cell renal cell carcinoma.
Fu RJ; He W; Wang XB; Li L; Zhao HB; Liu XY; Pang Z; Chen GQ; Huang L; Zhao KW
Cell Death Dis; 2017 Jul; 8(7):e2952. PubMed ID: 28749461
[TBL] [Abstract][Full Text] [Related]
14. IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
Xu L; Zhou R; Yuan L; Wang S; Li X; Ma H; Zhou M; Pan C; Zhang J; Huang N; Shi M; Bin J; Liao Y; Liao W
Cancer Lett; 2017 May; 393():76-85. PubMed ID: 28223169
[TBL] [Abstract][Full Text] [Related]
15. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.
Chen C; Bhalala HV; Vessella RL; Dong JT
Prostate; 2003 May; 55(2):81-8. PubMed ID: 12661032
[TBL] [Abstract][Full Text] [Related]
16. High expression of Krüppel-like factor 5 is associated with poor prognosis in patients with colorectal cancer.
Takagi Y; Sakai N; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takano S; Suzuki D; Kagawa S; Mishima T; Nakadai E; Miyauchi H; Matsubara H; Ohtsuka M
Cancer Sci; 2020 Jun; 111(6):2078-2092. PubMed ID: 32279400
[TBL] [Abstract][Full Text] [Related]
17. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer.
Hu B; Zhang K; Li S; Li H; Yan Z; Huang L; Wu J; Han X; Jiang W; Mulatibieke T; Zheng L; Wan R; Wang X; Hu G
Cancer Lett; 2016 Jul; 376(2):387-98. PubMed ID: 27085461
[TBL] [Abstract][Full Text] [Related]
18. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
[TBL] [Abstract][Full Text] [Related]
19. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
Wang Z; Qiu X; Zhang H; Li W
J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
[TBL] [Abstract][Full Text] [Related]
20. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
